case stringlengths 641 3.97k | reasoning stringlengths 324 937 | answer stringlengths 1.44k 6k | category stringclasses 4
values |
|---|---|---|---|
Mr. David Miller is a 52-year-old male admitted to the ICU following a massive pulmonary embolism (PE) complicated by cardiogenic shock. He has a history of poorly controlled Type 2 Diabetes Mellitus (HbA1c 9.2%), chronic kidney disease (CKD) stage 3 (eGFR 45 mL/min/1.73m²), and a prior history of atrial fibrillation m... | Massive PE with cardiogenic shock: high initial mortality.
Prolonged CPR increases neurological injury risk significantly.
Diabetes complicates recovery, impairs wound healing, infection risk.
CKD stage 3 worsens outcomes, limits treatment options.
Atrial fibrillation increases bleeding and thromboembolic risk.
Right v... | # Prognostic Assessment for Mr. David Miller
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller’s short-term prognosis is guarded. The initial 30-day mortality for patients with massive PE complicated by cardiogenic shock is estimated to be between 30-60%, even with optimal management. His prolonged CPR and persiste... | prognostic |
A 28-year-old female, Ms. Anya Sharma, presents with a known diagnosis of Takayasu Arteritis (TA) affecting the ascending aorta and left subclavian artery, diagnosed 3 years prior based on clinical, laboratory (elevated ESR/CRP, positive for ANCA – PR3), and imaging (CT angiography) findings. Initial treatment with hig... | Young age, but established multi-arterial TA involvement.
Persistent inflammation despite immunosuppressive therapy.
Subclavian stenosis causing significant limb ischemia.
Aortic root dilation – potential for dissection/aneurysm.
History of VTE increases future thrombotic risk.
Anxiety impacts adherence and disease per... | # Prognostic Assessment for Ms. Anya Sharma – Takayasu Arteritis
**Short-Term Prognosis (Days to Weeks):**
Ms. Sharma is at moderate risk for acute ischemic events related to the subclavian artery stenosis, particularly with continued exertion. There is a low risk of immediate aortic dissection given the current aorti... | prognostic |
A 6-month-old male infant, Mateo, of Ashkenazi Jewish descent, presents with progressively worsening hypotonia, failure to thrive, and recurrent respiratory infections. He was diagnosed with Spinal Muscular Atrophy (SMA) Type 1 at 3 months based on genetic testing confirming homozygous deletion of the *SMN1* gene. He i... | SMA Type 1: severe muscle weakness, rapid progression.
Age of onset <6 months: poorer prognostic indicator.
Respiratory insufficiency: immediate life-threatening risk.
Recurrent pneumonia: increased morbidity and mortality.
*SMN2* copy number: influences disease severity.
Low *SMN2* expression variant: worsens prognosi... | # Prognostic Assessment for Mateo - Spinal Muscular Atrophy Type 1
**Short-Term Prognosis (Days to Weeks):** Mateo’s short-term prognosis is guarded. He is at high risk for respiratory failure requiring escalation of respiratory support (potentially intubation and mechanical ventilation) and further episodes of aspira... | prognostic |
A 28-year-old G2P1 female presents with a confirmed diagnosis of Stage IIIC epithelial ovarian cancer (serous histology) following completion of neoadjuvant chemotherapy (paclitaxel and carboplatin) and interval debulking surgery. Surgical pathology revealed residual disease (less than 1cm) and positive pelvic and para... | Stage IIIC ovarian cancer indicates aggressive disease.
BRCA1 mutation predicts platinum sensitivity initially.
Residual disease impacts recurrence risk significantly.
Positive lymph nodes worsen overall prognosis.
Diabetes complicates treatment and recovery.
Diabetic nephropathy limits treatment options.
Psychosocial ... | # Prognostic Assessment: Stage IIIC Serous Ovarian Cancer
This 28-year-old patient with Stage IIIC serous ovarian cancer presents a complex prognostic scenario due to multiple interacting factors. Her prognosis is significantly impacted by the aggressive nature of her disease, the presence of residual disease, BRCA1 m... | prognostic |
Mr. David Miller is a 48-year-old male presenting with a known diagnosis of Stage IIIC, Grade 3 serous ovarian cancer, initially diagnosed 6 months ago in his wife, Sarah (52), who subsequently underwent genetic testing revealing a BRCA1 mutation. Mr. Miller was found to carry the same BRCA1 mutation during familial sc... | Stage IIIC ovarian cancer indicates advanced disease spread.
BRCA1 mutation signifies increased chemo-sensitivity, but recurrence.
Grade 3 histology suggests aggressive tumor biology.
Optimal debulking improves prognosis, but recurrence risk remains.
Rising CA-125 suggests potential disease progression.
Comorbidities (... | # Prognostic Assessment for Mr. David Miller – Stage IIIC Serous Ovarian Cancer
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller is currently stable but experiencing disease progression indicated by rising CA-125 and increasing ascites. He is at risk for symptom exacerbation (abdominal pain, bloating, dyspnea) req... | prognostic |
Mrs. Evelyn Reed is an 82-year-old Caucasian female presenting with a recent pathological fracture of the proximal femur following a minor fall at home. She has a known history of metastatic breast cancer (ER+, PR+, HER2-), diagnosed 8 years ago, initially treated with lumpectomy, radiation, and adjuvant aromatase ther... | Pathological fracture indicates advanced metastatic disease burden.
Age >80 significantly worsens fracture healing potential.
Multiple bone metastases signify widespread disease.
Hypercalcemia impacts overall physiological stability.
ECOG 2 suggests moderate functional impairment.
BRCA1 mutation may influence treatment... | # Prognostic Assessment for Mrs. Evelyn Reed
**Short-Term Prognosis (Days to Weeks):**
Mrs. Reed faces a high risk of complications in the immediate post-operative period following surgical fixation of the femoral fracture. These include wound infection, pneumonia, delirium, and further hypercalcemic crisis. Her corre... | prognostic |
Mr. Elias Vance, a 68-year-old African American male, presents 72 hours post-ingestion of a large quantity of acetaminophen (estimated 30g). He initially delayed seeking medical attention. He has a history of well-controlled hypertension, chronic kidney disease stage 3a (eGFR 48 mL/min/1.73m²), and mild depressive diso... | Acetaminophen toxicity: severe, established liver injury.
CKD stage 3a: increases toxicity, impairs NAC metabolism.
Hepatic encephalopathy: indicates significant liver failure.
High initial transaminases: correlate with poor outcomes.
Delayed presentation: reduces NAC effectiveness significantly.
Age 68: increases risk... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents with fulminant acetaminophen-induced hepatotoxicity complicated by pre-existing chronic kidney disease, early hepatic encephalopathy, and psychosocial vulnerabilities. His prognosis is guarded, requiring a nuanced assessment across multiple time horizons.
... | prognostic |
Mr. David Chen, a 48-year-old African American male, presents with Stage III Non-Small Cell Lung Cancer (NSCLC), adenocarcinoma histology, diagnosed 6 months ago. He initially presented with a cough and shortness of breath. Imaging revealed a 6cm primary tumor in the right upper lobe with mediastinal lymph node involve... | Stage III NSCLC indicates aggressive disease course.
EGFR mutation suggests targeted therapy responsiveness.
Disease progression post-chemotherapy is concerning.
Diabetes impacts immune function and healing.
CKD limits chemotherapy options and increases toxicity.
ECOG 2 signifies reduced functional capacity.
Smoking hi... | # Prognostic Assessment for Mr. David Chen
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen’s short-term prognosis is guarded. The recent disease progression despite initial chemotherapy response suggests a rapidly evolving disease state. He is at risk for symptom exacerbation (dyspnea, cough, fatigue) requiring pal... | prognostic |
Mr. David Miller is a 52-year-old male presenting for follow-up regarding established neovascular age-related macular degeneration (AMD) in his right eye. He was diagnosed 3 years ago and initially responded well to intravitreal aflibercept injections, achieving stable vision. However, over the past 6 months, he’s requ... | AMD severity: Active neovascularization, decreasing visual acuity.
Diabetes impacts: Increases AMD progression, vascular compromise.
Smoking history: Past smoking, still elevates AMD risk.
Injection frequency: Increasing frequency signals worsening disease.
OCT findings: Persistent fluid indicates treatment resistance.... | # Prognostic Assessment for Mr. David Miller – Neovascular AMD
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller is at high risk for further visual acuity decline in the right eye despite ongoing aflibercept treatment. Expect continued need for frequent (every 4 weeks) intravitreal injections to attempt stabilizati... | prognostic |
A 7-day-old male infant, born at 32 weeks gestation (birth weight 1.6kg), presents with worsening respiratory distress. He was diagnosed with Severe Combined Immunodeficiency (SCID) due to a complete loss-of-function mutation in the IL2RG gene, confirmed by genetic testing. He developed Pneumocystis jirovecii pneumonia... | SCID severity: complete IL2RG loss, early PCP infection.
Prematurity adds significant respiratory and systemic risk.
PCP treatment response uncertain, ongoing respiratory distress.
Neutropenia/lymphopenia: high infection risk, poor immune function.
Nutritional compromise worsens overall physiological reserve.
Family an... | # Prognostic Assessment for Neonatal SCID with PCP
This newborn with SCID presents a complex prognostic challenge due to multiple interacting factors. The underlying genetic defect (complete IL2RG loss) dictates a profoundly compromised immune system, but the clinical trajectory is significantly influenced by prematur... | prognostic |
A 28-year-old Hispanic female presents with a known diagnosis of high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC). Initial diagnosis at age 25 revealed high-grade urothelial carcinoma, Ta, high-risk features (multifocal, large tumor size >3cm, presence of carcinoma in sit... | NMIBC recurrence after BCG failure: poor prognosis.
High grade, CIS, multifocality: aggressive disease.
BCG unresponsiveness: increased risk of progression.
BRCA2 VUS: potential for genomic instability.
Crohn’s disease: impacts immune function, treatment.
Obesity: influences treatment options, outcomes.
Anxiety/ECOG 1:... | # Prognostic Assessment for BCG-Unresponsive NMIBC
This 28-year-old Hispanic female with BCG-unresponsive, high-risk NMIBC presents a complex prognostic challenge. Her case is complicated by multiple factors suggesting a potentially aggressive disease course and limited treatment options.
**Short-Term Prognosis (Days... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male presenting with worsening fatigue, easy bruising, and recurrent epistaxis over the past 3 months. He was diagnosed 6 months ago with Chronic Lymphocytic Leukemia (CLL), Rai Stage III, with del(17p) and *TP53* mutation identified on FISH analysis. His initial absolute lymphoc... | CLL stage III indicates advanced disease burden.
Del(17p)/TP53 mutation: very high-risk genetic feature.
Rapid lymphocyte doubling time suggests aggressive course.
Anemia and thrombocytopenia: symptomatic disease progression.
Renal insufficiency complicates treatment options.
Diabetes increases infection risk, treatmen... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon is at moderate risk of near-term complications related to progressive cytopenias. The declining hemoglobin and platelet count increase the risk of bleeding and infection. His worsening renal function adds to this... | prognostic |
A 28-year-old African American female with a history of Systemic Lupus Erythematosus (SLE) diagnosed at age 16, presents to the Emergency Department with acute chest pain and shortness of breath. She reports a 3-day history of worsening pleuritic chest pain, non-productive cough, and fatigue. She has been non-compliant... | SLE flare with serositis, cardiac involvement confirmed.
Renal insufficiency complicates management, poor baseline function.
Troponin elevation suggests myocardial involvement/inflammation.
Tamponade physiology requires immediate intervention.
Non-compliance worsens prognosis, disease activity increased.
*FCGR2A* polym... | # Prognostic Assessment for SLE Flare with Cardiac and Renal Involvement
This 28-year-old African American female with a history of SLE presents a complex case with a high degree of prognostic uncertainty. Her acute presentation of pericarditis with tamponade, coupled with acute kidney injury and evidence of myocardia... | prognostic |
Ethan, a 9-year-old male, presents with relapsed B-cell Acute Lymphoblastic Leukemia (ALL). He was initially diagnosed 2 years ago with common ALL and completed frontline chemotherapy based on the Children’s Oncology Group (COG) AALL1131 protocol, achieving morphological remission. He relapsed with bone marrow involvem... | Relapsed ALL indicates poorer initial treatment response.
High blast percentage signifies aggressive disease burden.
*KMT2A* rearrangement associated with higher relapse risk.
*TP53* mutation predicts chemoresistance and poor outcome.
MRD positivity post-induction worsens prognosis significantly.
Asthma, obesity may co... | # Prognostic Assessment for Ethan – Relapsed B-ALL
**Short-Term Prognosis (Days to Weeks):**
Ethan faces a high risk of treatment-related complications due to the aggressive nature of his relapse and cytopenias. Achieving remission following salvage chemotherapy will be challenging. There is a significant risk of infe... | prognostic |
A 52-year-old female, previously a smoker (20 pack-years, quit 5 years ago), presents with newly diagnosed Stage IV (T2N3M1) non-small cell lung cancer (NSCLC) with adenocarcinoma histology. The primary tumor is located in the right upper lobe, with mediastinal lymph node involvement and distant metastasis to the left ... | Stage IV NSCLC indicates inherently poor prognosis.
High TMB suggests potential immunotherapy responsiveness.
Adrenal metastasis signifies extensive disease spread.
ECOG 1 indicates moderate functional impairment.
Diabetes and CKD complicate treatment tolerance.
PD-L1 30% suggests moderate immunotherapy benefit.
Psycho... | # Prognostic Assessment for Stage IV NSCLC
This 52-year-old female with Stage IV NSCLC presents a complex prognostic scenario. Her prognosis is significantly impacted by multiple factors, necessitating a nuanced assessment.
**Short-Term Prognosis (Days to Weeks):**
Initially, the short-term prognosis is focused on sy... | prognostic |
A 16-year-old female, G2P1, presents with a confirmed diagnosis of Stage IIIC epithelial ovarian cancer (serous histology) following surgical debulking. Initial presentation was with abdominal distension and pain. Pathology revealed high-grade serous carcinoma with positive lymph node involvement (pelvic and para-aorti... | Stage IIIC indicates advanced disease, poor prognosis.
Suboptimal response to chemotherapy worsens outlook.
High-grade serous histology is aggressive.
Diabetes complicates treatment, increases infection risk.
Adolescent age presents unique physiological challenges.
Limited social support impacts adherence, wellbeing.
A... | # Prognostic Assessment: Stage IIIC Ovarian Cancer in Adolescent
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is guarded, primarily due to the residual disease following neoadjuvant chemotherapy and the patient’s comorbidities. She is at increased risk of complications from further chemotherapy, ... | prognostic |
Mr. Elias Thorne is a 93-year-old male presenting with worsening vision in his right eye. He was diagnosed 3 years ago with non-center involving diabetic retinopathy (NC-DR) in both eyes, managed with annual dilated fundus exams. He also has a history of well-controlled hypertension, chronic kidney disease stage 3a (eG... | Advanced PDR with NVD indicates high risk progression.
Age >90 significantly worsens visual outcome probabilities.
CKD stage 3a impacts treatment response and healing.
Macular edema exacerbates vision loss potential.
Poor glycemic control fuels retinopathy progression.
Cognitive impairment hinders treatment adherence.
... | # Prognostic Assessment for Mr. Elias Thorne
**Short-Term Prognosis (Days to Weeks):**
Mr. Thorne is at high risk for rapid vision loss in the right eye due to the proliferative diabetic retinopathy with neovascularization of the disc and associated macular edema. Without intervention, there is a significant (estimate... | prognostic |
Mr. David Miller is a 52-year-old male presenting for prognostic assessment following a recent diagnosis of high-risk non-muscle invasive bladder cancer (NMIBC). He was initially evaluated for hematuria and found to have a cT1G3pTa tumor involving the posterior bladder wall. Transurethral resection of bladder tumor (TU... | High-grade NMIBC with CIS indicates aggressive disease.
Recurrence risk significantly elevated with CIS involvement.
Diabetes impairs immune response, affecting BCG efficacy.
CKD impacts BCG delivery and increases infection risk.
Smoking history increases risk of secondary malignancies.
LUTS suggest potential functiona... | # Prognostic Assessment for Mr. David Miller
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller faces a moderate risk of complications related to the initiation of intravesical BCG therapy. These include irritative voiding symptoms (dysuria, frequency, urgency), systemic symptoms resembling a mild flu-like illness (... | prognostic |
A 2.5-year-old male of Ashkenazi Jewish descent presents with newly diagnosed Spinal Muscular Atrophy Type 1 (SMA1). He was initially noted to have generalized hypotonia at 3 months, progressively worsening to significant weakness. Genetic testing confirmed homozygous deletion of the *SMN1* gene. He currently requires ... | SMA1 severity: rapid progression, early respiratory compromise.
Genetic background: Ashkenazi Jewish ancestry, higher carrier rate.
Age at symptom onset: earlier onset, worse prognosis.
Respiratory function: NIPPV dependence indicates severe impairment.
Nutritional status: failure to thrive worsens overall health.
Recu... | # Prognostic Assessment for SMA1 in a 2.5-Year-Old Male
**Short-Term Prognosis (Days to Weeks):**
The patient faces a high risk of respiratory failure requiring escalation of respiratory support (e.g., intubation and mechanical ventilation) despite NIPPV. Recurrent respiratory infections are likely, potentially lead... | prognostic |
A 7-day-old male infant, born at 32 weeks gestation (birth weight 1.6kg), presents with bilateral hydronephrosis detected on routine neonatal ultrasound. Prenatal history is significant for maternal gestational diabetes, poorly controlled. Postnatal course has been complicated by respiratory distress syndrome requiring... | Prematurity increases risk of renal complications.
Gestational diabetes links to congenital anomalies.
High-grade VUR predicts UTI and renal damage.
Reduced renal function impacts long-term outcome.
African American ethnicity: higher CKD risk.
Family history suggests genetic predisposition to CKD.
Bilateral involvement... | # Prognostic Assessment for Bilateral Vesicoureteral Reflux in a Preterm Infant
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is guarded but stable. The infant is currently asymptomatic, but carries a high risk of symptomatic urinary tract infections (UTIs) within the first year of life. The risk ... | prognostic |
A 52-year-old female presents with a 3-year history of progressive cutaneous lupus erythematosus (CLE), specifically discoid lupus erythematosus (DLE) transitioning to subacute cutaneous lupus erythematosus (SCLE) with photosensitivity. Initial diagnosis was confirmed with skin biopsy showing interface dermatitis, posi... | DLE/SCLE overlap indicates more aggressive disease course.
Positive anti-Ro/SSA links to neonatal lupus risk.
Coexisting systemic sclerosis complicates prognosis significantly.
Raynaud’s suggests potential for digital ulceration.
Smoking worsens vascular disease and lupus activity.
Obesity increases inflammation and tr... | # Prognostic Assessment for Cutaneous and Systemic Lupus Erythematosus with Systemic Sclerosis Overlap
This 52-year-old female presents a complex case with overlapping autoimmune conditions, demanding a nuanced prognostic assessment. Her disease course, characterized by a transition from DLE to SCLE, coupled with the ... | prognostic |
Mr. David Lee, a 52-year-old African American male, is admitted to the ICU following a witnessed out-of-hospital cardiac arrest (OHCA) secondary to acute myocardial infarction (STEMI) – anterior wall. ROSC was achieved after 8 minutes of CPR with bystander CPR initiated. He was initially treated with thrombolytics in t... | Cardiac arrest etiology: STEMI, poor initial perfusion.
Prolonged CPR duration: significant neurological injury risk.
Comorbidities: diabetes, CKD, PAD worsen outcomes.
Neurological status: encephalopathy indicates brain injury.
LVEF severely reduced: increased heart failure risk.
Renal dysfunction: limits treatment op... | # Prognostic Assessment for Mr. David Lee
**Short-Term Prognosis (Days to Weeks):**
Mr. Lee’s short-term prognosis is guarded. He is at high risk for multi-organ dysfunction, including acute respiratory distress syndrome (ARDS), secondary neurological injury, and cardiac complications (arrhythmias, cardiogenic shock).... | prognostic |
An 8-year-old male of Ashkenazi Jewish descent presents with a confirmed diagnosis of Juvenile Nasopharyngeal Undifferentiated Sinonasal Carcinoma (JNU-USC), Stage III. He initially presented with nasal obstruction, epistaxis, and left facial swelling. Biopsy revealed poorly differentiated carcinoma, positive for MYC r... | JNU-USC Stage III indicates aggressive disease potential.
MYC rearrangement signifies poor prognosis, rapid progression.
Partial response to chemotherapy is encouraging, not curative.
Sphenoid sinus involvement increases recurrence risk.
Asthma, well-controlled, minimal impact on prognosis.
BRCA1 family history suggest... | # Prognostic Assessment for Juvenile Nasopharyngeal Undifferentiated Sinonasal Carcinoma (JNU-USC)
This 8-year-old male with Stage III JNU-USC presents a complex prognostic scenario due to multiple interacting factors. JNU-USC is a rare and aggressive malignancy, and prognosis is significantly influenced by stage, res... | prognostic |
Mrs. Elena Rodriguez is an 82-year-old Hispanic female admitted to the hospital with acute decompensated heart failure (ADHF) exacerbation. She has a history of ischemic cardiomyopathy (EF 30%, NYHA Class III), chronic kidney disease (CKD stage 3b, eGFR 35 mL/min/1.73m²), type 2 diabetes mellitus (HbA1c 8.2%), and mild... | Cardiomyopathy severity: significantly reduced ejection fraction, NYHA III.
CKD stage impacts diuretic response and overall survival.
Diabetes complicates HF management, increases mortality risk.
MCI affects medication adherence, self-care capabilities.
Social isolation limits support, hinders recovery potential.
Eleva... | # Prognostic Assessment for Mrs. Elena Rodriguez
Mrs. Rodriguez presents a complex geriatric syndrome with multiple interacting comorbidities significantly impacting her prognosis. Her case requires a nuanced assessment considering physiological, functional, and psychosocial factors.
**Short-Term Prognosis (Days to W... | prognostic |
A 16-year-old African American female presents with a 6-month history of progressive vision loss in her left eye. Initial examination revealed a large, choroidal melanoma (diameter 15mm, thickness 8mm) located 3 disc diameters from the fovea. Ultrasound B-scan confirmed the lesion’s height and presence of subtle choroi... | Large tumor size indicates higher metastatic risk.
BRCA1 mutation worsens prognosis significantly.
Choroidal detachment suggests aggressive behavior.
Age under 25 correlates with poorer outcomes.
Asthma, while controlled, impacts systemic health.
Psychosocial distress hinders treatment adherence.
African American ethni... | # Prognostic Assessment for Choroidal Melanoma
This 16-year-old female with a large choroidal melanoma presents a complex prognostic challenge due to multiple high-risk factors.
**Short-Term Prognosis (Days to Weeks):**
Immediate prognosis focuses on treatment planning and minimizing anxiety. The patient will likely... | prognostic |
A 72-year-old African American female with a history of hypertension, type 2 diabetes mellitus (HbA1c 8.2%), chronic kidney disease stage 3a (eGFR 48 mL/min/1.73m²), and prior myocardial infarction (stent placed 5 years ago) presents for elective transcatheter aortic valve replacement (TAVR). She reports worsening dysp... | Severe aortic stenosis impacts short-term surgical risk.
Comorbid CAD increases perioperative myocardial event probability.
CKD stage 3a elevates fluid/electrolyte imbalance risk.
Diabetes complicates wound healing and infection control.
Prior MI suggests reduced cardiac reserve capacity.
Frailty score predicts postope... | # Prognostic Assessment for TAVR in a 72-Year-Old Female
This patient presents a complex case for prognostic assessment due to multiple interacting comorbidities and risk factors. Her severe aortic stenosis necessitates intervention, but her overall health status significantly influences expected outcomes.
**Short-Te... | prognostic |
A 68-year-old female presents with a 5-year history of seropositive Rheumatoid Arthritis (RA). Initially managed with methotrexate, she developed progressive disease despite escalation to leflunomide and sulfasalazine. Two years ago, she started on tocilizumab, achieving partial remission. However, over the past 6 mont... | RA seropositivity indicates more aggressive disease course.
Established erosions suggest irreversible joint damage present.
Tocilizumab failure signals treatment refractoriness concern.
Comorbidities (DM, HTN, CVD) worsen overall prognosis.
High inflammatory markers indicate active disease state.
Functional impairment ... | # Prognostic Assessment for Rheumatoid Arthritis
This 68-year-old female with long-standing, seropositive RA presents a complex prognostic challenge due to multiple interacting factors. Her disease is demonstrably progressive despite multiple DMARDs and biologic therapy, indicating a poor response to treatment and a h... | prognostic |
A 9-year-old female presents with acute myeloid leukemia (AML), diagnosed 3 months ago. She initially achieved remission with induction chemotherapy (cytarabine and daunorubicin) but relapsed 6 weeks later. Her relapse is characterized by extramedullary disease involving the central nervous system (CNS) – confirmed by ... | AML relapse with CNS involvement: poor prognostic indicator.
Complex karyotype (monosomy 7): significantly worsens outcome.
FLT3-ITD mutation: associated with higher relapse risk.
Neutropenia increases infection risk, delaying therapy.
Performance status 70%: limits treatment tolerance.
Asthma: potential for respirator... | # Prognostic Assessment for Relapsed AML with CNS Involvement
This 9-year-old female with relapsed AML, complicated by CNS involvement, a complex karyotype, and FLT3-ITD mutation, faces a grave prognosis. Multiple factors contribute to a significantly diminished likelihood of long-term survival and a substantial risk ... | prognostic |
Mr. Elias Vance is a 72-year-old African American male with a history of Parkinson’s Disease (PD) diagnosed 8 years ago (Hoehn & Yahr Stage III, presenting with rigidity, tremor, and postural instability). He was relatively stable until 6 months ago when he began experiencing increased falls (3 in the last month, one r... | PD stage III indicates moderate disease severity.
Frequent falls signify increased morbidity risk.
Renal function decline suggests frailty progression.
Low albumin indicates nutritional compromise.
Mild cognitive impairment impacts self-management.
LRRK2 mutation suggests potentially faster progression.
Social isolatio... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex geriatric case with multiple interacting factors impacting his prognosis. His Parkinson’s Disease, coupled with emerging frailty, cognitive impairment, and psychosocial distress, necessitates a nuanced assessment.
**Short-Term Prognosis (Days to... | prognostic |
A 28-year-old female presents with a history of high-grade, non-muscle invasive bladder cancer (HG-NMIBC), initially diagnosed 18 months ago. Initial transurethral resection of bladder tumor (TURBT) revealed pT1G3, high-grade urothelial carcinoma. Subsequent intravesical BCG therapy (6 weekly instillations followed by ... | High-grade, recurrent NMIBC after BCG failure: concerning.
Multiple lesions suggest aggressive disease behavior.
Crohn’s/azathioprine: immunosuppression impacts treatment response.
Smoking: increases recurrence and progression risk.
Family history ovarian cancer: potential genetic predisposition.
Anxiety/non-adherence:... | # Prognostic Assessment for Recurrent High-Grade NMIBC
This 28-year-old female with recurrent, high-grade NMIBC following BCG failure presents a complex prognostic challenge. Her case is complicated by multiple adverse risk factors and comorbidities.
**Short-Term Prognosis (Days to Weeks):**
Her immediate prognosis i... | prognostic |
A 28-year-old African American female presents with known hypertrophic cardiomyopathy (HCM), diagnosed at age 16 following a family history of sudden cardiac death (SCD). Her father died at age 42 during exercise. She is NYHA class II, experiencing dyspnea on moderate exertion and occasional chest discomfort. Echocardi... | HCM severity: significant hypertrophy, MR, LA dilation, fibrosis.
Genetic mutation: MYBPC3 linked to increased SCD risk.
AFib presence: elevates stroke and heart failure risk.
Diabetes: accelerates cardiovascular disease progression.
Obesity: worsens HCM symptoms, increases cardiac strain.
PVC frequency: potential arrh... | # Prognostic Assessment for Hypertrophic Cardiomyopathy
This 28-year-old female with HCM presents a complex prognostic challenge due to multiple interacting risk factors. Her case is considered high-risk, demanding careful and ongoing assessment.
**Short-Term Prognosis (Days to Weeks):**
Relatively stable, but at inc... | prognostic |
Ms. Anya Sharma, a 48-year-old Filipina woman, presents with Stage III Invasive Ductal Carcinoma (IDC), HER2-positive, diagnosed 6 months ago. She initially responded to neoadjuvant chemotherapy (AC-T regimen) with a good pathological complete response (pCR) in the breast, but recent imaging reveals metastatic disease ... | Stage III metastatic HER2+ breast cancer present.
BRCA1 mutation indicates aggressive disease course.
Good initial response, now metastatic progression.
Lung and bone metastases impact prognosis.
Diabetes and hypertension add comorbidity burden.
ECOG 1, but declining functional status noted.
PD-L1 30% suggests potentia... | # Prognostic Assessment for Ms. Anya Sharma
Ms. Sharma presents a complex case of metastatic HER2-positive breast cancer with multiple factors influencing her prognosis. Her initial response to neoadjuvant chemotherapy was encouraging, but the development of distant metastases significantly alters her outlook.
**Shor... | prognostic |
Mr. David Miller is a 48-year-old male with a 15-year history of Bipolar I Disorder, currently presenting with a severe depressive episode. He was initially diagnosed following a manic episode triggered by sleep deprivation during a period of high work stress. His illness has been characterized by rapid cycling (at lea... | Bipolar I, severe depression, rapid cycling, poor adherence.
Substance use history increases relapse and complication risk.
Comorbid diabetes impacts overall health and treatment.
Social isolation exacerbates depressive symptoms, hinders recovery.
Prior hospitalizations indicate illness severity, treatment resistance.
... | # Prognostic Assessment for Mr. David Miller
Mr. Miller presents a complex case with multiple factors influencing his prognosis. His long-standing Bipolar I Disorder, characterized by rapid cycling and mixed features, suggests a more challenging course than typical Bipolar I. His current severe depressive episode, cou... | prognostic |
A 48-year-old African American female, Ms. Evelyn Reed, presents with a known diagnosis of Stage IIIB (T3N2M0) HER2-positive invasive ductal carcinoma of the left breast, diagnosed 6 months ago. She initially underwent neoadjuvant chemotherapy (AC-T regimen) followed by lumpectomy and sentinel lymph node biopsy reveali... | Stage IIIB HER2+ breast cancer, high recurrence risk.
BRCA1 mutation worsens prognosis significantly.
Poorly controlled diabetes impacts treatment tolerance.
Hypertension, manageable, less prognostic impact.
Suspicious lung lesion suggests potential metastasis.
ECOG 1 indicates moderate functional impairment.
Limited s... | # Prognostic Assessment for Ms. Evelyn Reed
Ms. Reed presents a complex case with multiple factors influencing her prognosis. Her established Stage IIIB HER2-positive breast cancer, coupled with a BRCA1 mutation, places her at significantly higher risk of recurrence and poorer overall survival compared to patients wit... | prognostic |
A 16-year-old male, previously healthy, presents with a 6-month history of progressive weakness and sensory changes, initially in his lower limbs, now ascending to involve his upper limbs. Diagnosis: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), confirmed by nerve conduction studies (NCV) showing distal lat... | CIDP severity: EDSS 4.0 indicates moderate functional impairment.
Asthma control: Well-controlled asthma is a minor prognostic factor.
ADHD: Stimulant use may interact with CIDP treatment.
Family history: RA suggests potential autoimmune predisposition.
ANA positivity: Raises concern for overlapping autoimmune conditio... | # Prognostic Assessment for CIDP in a 16-Year-Old Male
This case presents a complex scenario requiring careful prognostic assessment due to the interplay of CIDP, comorbidities, psychosocial factors, and limited treatment response.
**Short-Term Prognosis (Days to Weeks):**
Given the lack of significant improvement o... | prognostic |
Mr. David Lee is a 52-year-old African American male with a history of poorly controlled Type 2 Diabetes Mellitus (diagnosed 15 years ago, HbA1c consistently >8.5%), hypertension (diagnosed 10 years ago, currently on 3 medications), hyperlipidemia (diagnosed 8 years ago), and a 25 pack-year smoking history. He presents... | Acute limb ischemia: severity dictates immediate risk.
Diabetes complicates healing, increases infection risk.
Renal insufficiency limits intervention options.
Smoking history worsens peripheral vascular disease.
TASC II C lesion: complex revascularization challenge.
APOE4 allele: increased cardiovascular risk potentia... | # Prognostic Assessment for Mr. David Lee
Mr. Lee presents with a complex case of acute limb ischemia superimposed on significant underlying vascular disease and multiple comorbidities. His prognosis is guarded and requires a nuanced assessment.
**Short-Term Prognosis (Days to Weeks):**
Mr. Lee faces a high risk of l... | prognostic |
A 6-month-old male infant presents with confirmed diagnosis of Severe Combined Immunodeficiency (SCID) due to ADA deficiency, diagnosed via newborn screening and confirmed by low T-cell and B-cell counts, absent phytohemagglutinin response, and genetic testing revealing biallelic pathogenic variants in the *ADA* gene. ... | SCID severity: ADA deficiency, recurrent severe infections.
Early age of onset indicates aggressive disease course.
Multiple infections suggest impaired immune reconstitution.
Fungal infection signifies profound immunodeficiency.
Failure to thrive impacts overall health and resilience.
VSD adds cardiac risk, potentiall... | # Prognostic Assessment for Severe Combined Immunodeficiency (SCID) - ADA Deficiency
This 6-month-old male with ADA-SCID presents a complex prognostic scenario due to multiple high-risk factors. His prognosis is significantly guarded, even with optimal management.
**Short-Term Prognosis (Days to Weeks):**
High risk o... | prognostic |
A 48-year-old female, Ms. Eleanor Vance, presents with Stage IV HER2-positive metastatic breast cancer initially diagnosed 3 years ago. She initially responded well to neoadjuvant chemotherapy (AC-T) followed by adjuvant trastuzumab and radiation. However, she now presents with progressive disease involving bone (multi... | Stage IV HER2+ breast cancer: poor overall prognosis.
Visceral crisis (liver, lung): rapidly declining function.
Hypercalcemia: indicates aggressive disease, poor prognosis.
ECOG 2: limited functional capacity, impacts treatment.
PIK3CA mutation: potential targeted therapy response.
Comorbidities (DM, HTN, COPD): compl... | # Prognostic Assessment for Ms. Eleanor Vance
Ms. Vance presents with a complex case of metastatic HER2-positive breast cancer with multiple adverse prognostic factors. Her prognosis requires careful consideration of disease-specific factors, comorbidities, functional status, and psychosocial well-being.
**Short-Term... | prognostic |
A 6-month-old male infant presents with confirmed congenital diaphragmatic hernia (CDH) – Bochdalek type, repaired at birth. Initial postnatal course was complicated by severe pulmonary hypertension requiring prolonged ECMO support (14 days). He has chronic lung disease (CLD) requiring ongoing oxygen support (0.3L/min ... | CDH severity: ECMO use indicates high initial severity.
Lung hypoplasia: Moderate hypoplasia limits respiratory reserve.
BO presence: Indicates irreversible airway obstruction, worsening CLD.
Recurrent infections: Compromised immunity, accelerating lung damage.
*FOXF7* mutation: Increases CLD risk and potential recurre... | # Prognostic Assessment for 6-Month-Old Male with Repaired CDH
This infant with a history of congenital diaphragmatic hernia (CDH) presents a complex prognostic challenge due to multiple interacting factors. His initial severity, evidenced by the need for prolonged ECMO support, coupled with ongoing respiratory compro... | prognostic |
A 48-year-old G3P2 female presents with a known diagnosis of Stage IIIC high-grade serous ovarian cancer, initially diagnosed 18 months ago. She underwent neoadjuvant chemotherapy (6 cycles of carboplatin and paclitaxel) followed by interval debulking surgery. Pathology post-surgery revealed residual disease (approxima... | Stage IIIC recurrence indicates aggressive disease biology.
BRCA negativity limits PARP inhibitor re-treatment options.
Peritoneal carcinomatosis worsens prognosis significantly.
Diabetes and CKD increase treatment toxicity risk.
ECOG 1 suggests reasonable functional reserve currently.
Psychological distress impacts tr... | # Prognostic Assessment: Recurrent High-Grade Serous Ovarian Cancer
This 48-year-old patient with Stage IIIC recurrent high-grade serous ovarian cancer presents a complex prognostic scenario. Multiple factors contribute to a guarded outlook, but some elements suggest potential for response to further treatment.
**Sho... | prognostic |
A 28-year-old male presents with a 6-month history of worsening Crohn’s disease, initially diagnosed ileocolonically two years prior. He was initially managed with mesalamine, but disease progressed requiring initiation of infliximab 18 months ago. Despite infliximab, he’s experienced frequent flares (every 3-4 months)... | Active Crohn’s despite anti-TNF; poor response indicator.
Frequent flares suggest aggressive disease phenotype.
Low albumin indicates malnutrition, impacting healing.
Elevated CRP/ESR confirm significant inflammation.
Ileal stricture raises concern for future complications.
Perianal fistulas suggest more complex diseas... | # Prognostic Assessment for Crohn’s Disease
This 28-year-old male with Crohn’s disease presents a challenging prognostic scenario due to multiple adverse factors despite relatively young age. His disease is aggressive, refractory to first-line biologic therapy, and complicated by structural damage and extraintestinal ... | prognostic |
Mr. David Miller is a 52-year-old male with a 3-year history of Crohn’s Disease, initially diagnosed with ileocolonic involvement. He presented initially with abdominal pain, diarrhea (bloody), and weight loss. He was initially managed with mesalamine, then transitioned to infliximab due to lack of response. He experie... | Crohn’s severity: stricturing, obstruction, malnutrition, inflammation.
Smoking significantly worsens Crohn’s disease course.
Low albumin indicates severe inflammation/malnutrition.
Ileal obstruction: immediate surgical intervention likely.
Psychosocial factors impact adherence and recovery.
Comorbid hypertension: pote... | # Prognostic Assessment for Mr. David Miller
Mr. Miller presents a complex case of Crohn’s Disease with multiple high-risk features, necessitating a detailed prognostic assessment. His disease is characterized by a stricturing phenotype, active inflammation, and now, near-complete ileal obstruction, indicating a sever... | prognostic |
A 52-year-old female, Ms. Eleanor Vance, presents for follow-up regarding a recently diagnosed (3 months ago) locally advanced squamous cell carcinoma (SCC) of the oropharynx (primary site: tonsil). Initial staging (AJCC 8th edition) was pT3N2bM0, Stage III. She completed definitive chemoradiation therapy (cisplatin-ba... | Oropharyngeal SCC, Stage III, post-chemoradiation therapy.
Complete metabolic response initially, now lung nodule concern.
Dysphagia indicates treatment-related morbidity, impacting nutrition.
Smoking history increases risk of second primary cancers.
Diabetes impacts wound healing and immune function.
ECOG 1 suggests m... | # Prognostic Assessment for Ms. Eleanor Vance
Ms. Vance presents a complex case with a recently treated locally advanced oropharyngeal SCC and a concerning finding of a potentially metastatic pulmonary nodule. Her prognosis is significantly impacted by multiple interacting factors.
**Short-Term Prognosis (Days to Wee... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male presenting for follow-up of Stage III (T3N1M0) Non-Small Cell Lung Cancer (NSCLC), adenocarcinoma histology, diagnosed 6 months ago. He completed 6 cycles of cisplatin/pemetrexed chemotherapy 3 months ago, achieving a partial response on imaging. He is a former smoker with a ... | NSCLC stage III, partial response, but disease progression.
Smoking history: high pack-years, increased recurrence risk.
Diabetes poorly controlled, impacts immune function/healing.
CKD stage 3a: limits chemotherapy options, increases toxicity.
PAD: limits exercise tolerance, impacts quality of life.
ECOG 1: moderate f... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case with multiple factors influencing his prognosis. His Stage III NSCLC, despite initial response to chemotherapy, is demonstrating signs of progression with a new pleural effusion and suspicious contralateral nodule. This significan... | prognostic |
A 16-year-old female, Sarah, presents with a 18-month history of systemic juvenile idiopathic arthritis (SJIA). Diagnosis confirmed via IL-6 elevation, negative ANA/RF/anti-CCP, and exclusion of other causes. Initial presentation involved high spiking fevers, evanescent rash, and arthritis affecting knees, wrists, and ... | SJIA severity: persistent systemic features, incomplete treatment response.
Delayed bone age indicates potential growth impairment risk.
High inflammatory markers suggest ongoing disease activity.
Methotrexate failure signals need for alternative therapies.
Fatigue significantly impacts functional status and QoL.
Depre... | # Prognostic Assessment for Sarah – Systemic Juvenile Idiopathic Arthritis
**Short-Term Prognosis (Days to Weeks):**
Sarah is at risk for continued flares of SJIA despite current treatment. The persistent systemic features (fever, fatigue) and elevated inflammatory markers suggest ongoing disease activity. There is a ... | prognostic |
A 16-year-old female, Sarah, presents with a confirmed diagnosis of Stage III High-Risk Hodgkin Lymphoma, Classical Hodgkin Lymphoma, nodular sclerosis subtype. Initial presentation included a rapidly enlarging cervical lymph node, night sweats, unintentional weight loss (10% body weight over 3 months), and persistent ... | Stage III, high-risk features indicate aggressive disease.
Bulky disease worsens prognosis significantly.
Elevated LDH and beta-2 microglobulin are adverse.
Asthma adds comorbidity, potential treatment limitations.
ECOG 1 suggests moderate functional impairment.
Psychosocial distress impacts adherence and outcomes.
Fin... | # Prognostic Assessment for Sarah - Stage III High-Risk Hodgkin Lymphoma
**Short-Term Prognosis (Days to Weeks):**
Sarah's immediate prognosis is focused on tolerating initial chemotherapy (likely ABVD). She is at risk for treatment-related toxicities, particularly neutropenia and infections given her age and bulky d... | prognostic |
Mr. David Miller is a 52-year-old male presenting for follow-up regarding Chronic Myeloid Leukemia (CML) in chronic phase, diagnosed 3 years ago. He initially responded well to first-line imatinib, achieving a complete cytogenetic response within 6 months. However, over the past 6 months, he’s experienced increasing fa... | CML phase transitioning; rising BCR-ABL1 transcript levels.
JAK2 mutation suggests accelerated phase potential.
Diabetes impacts immune function, treatment tolerance.
Smoking history increases cardiovascular risk, complications.
Financial stress affects adherence, mental wellbeing.
ECOG 1 indicates relatively good func... | # Prognostic Assessment for Mr. David Miller
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller is at immediate risk of progressing to accelerated phase CML. The rising BCR-ABL1 transcript levels and increasing blast percentage in the bone marrow necessitate prompt intervention. Without treatment modification, he is... | prognostic |
A 28-year-old female presents with a 6-month history of worsening Crohn’s disease, initially diagnosed at age 16 with ileal involvement. She has experienced frequent flares despite multiple therapies (mesalamine, azathioprine, and currently on infliximab). Recent imaging (MRI enterography) reveals extensive small bowel... | Extensive disease: small bowel & colon inflammation present.
Prior therapy failure: multiple lines already ineffective.
Low albumin: indicates significant inflammation/malnutrition.
Elevated CRP/ESR: confirms active inflammatory process.
Anemia present: likely iron deficiency/chronic disease.
Vitamin D deficiency: impa... | # Prognostic Assessment for Crohn's Disease
This 28-year-old female with Crohn’s disease presents a complex case with multiple factors influencing her prognosis. Her disease is aggressive, refractory to multiple therapies, and associated with significant systemic inflammation and functional impairment.
**Short-Term P... | prognostic |
A 2.5-year-old female presents with a confirmed diagnosis of Congenital Adrenal Hyperplasia (CAH) due to 21-hydroxylase deficiency, salt-wasting form, diagnosed at birth via newborn screening. She has been on hydrocortisone and fludrocortisone replacement therapy since 6 weeks of age. Despite adherence, she experiences... | CAH severity: Salt-wasting form indicates significant enzyme deficiency.
Frequent crises: Suggests suboptimal glucocorticoid replacement.
Growth deceleration: Indicates chronic glucocorticoid insufficiency.
Delayed bone age: Reflects long-term growth hormone impact.
Family history: Hypertension/diabetes increases metab... | # Prognostic Assessment for Congenital Adrenal Hyperplasia (CAH)
This 2.5-year-old female with salt-wasting CAH presents a complex prognostic challenge due to multiple interacting factors. Her prognosis needs to be considered across short, medium, and long-term horizons.
**Short-Term Prognosis (Days to Weeks):**
The... | prognostic |
A 52-year-old female with a history of systemic sclerosis (SSc) limited cutaneous subtype (lcSSc) for 15 years, diagnosed based on ACR/EULAR 2013 criteria, presents for elective right total hip arthroplasty (THA) due to severe osteoarthritis. Her SSc has been relatively stable for the past 5 years, managed with mycophe... | SSc severity: limited subtype, moderate organ involvement.
Digital ulcers indicate vascular disease progression.
Pulmonary hypertension increases perioperative risk.
CKD impacts drug metabolism and renal safety.
Anemia contributes to reduced oxygen carrying capacity.
Low albumin suggests malnutrition, impaired healing.... | # Prognostic Assessment for THA in Systemic Sclerosis
This 52-year-old female with lcSSc presents a complex prognostic challenge due to multiple interacting conditions. Her underlying SSc, coupled with comorbidities and recent disease progression, significantly impacts her perioperative and long-term outlook.
**Short... | prognostic |
A 7-day-old male infant, born at 32 weeks gestation (birth weight 1.6kg), presents with worsening respiratory distress. He was diagnosed with Hypoplastic Left Heart Syndrome (HLHS) via fetal echocardiogram and confirmed postnatally. He has been maintained on prostaglandin E1 (PGE1) since birth to keep the ductus arteri... | HLHS severity: critically dependent on ductal patency.
Gestational age impacts: prematurity increases complications.
Renal function: insufficiency worsens overall prognosis.
Genetic mutation: *NOTCH1* suggests neurodevelopmental risk.
PGE1 dependence: prolonged use has side effects.
Maternal psychosocial stress: impact... | # Prognostic Assessment for Neonate with HLHS
This neonate with Hypoplastic Left Heart Syndrome (HLHS) presents a complex prognostic challenge due to multiple interacting factors. Prognosis must be considered across short, medium, and long-term horizons.
**Short-Term Prognosis (Days to Weeks):**
The immediate progno... | prognostic |
A 9-month-old female infant presents with a 6-month history of systemic juvenile idiopathic arthritis (SJIA). Initial presentation included high spiking fevers, evanescent rash, and significant irritability. Diagnosis confirmed by exclusion of other causes, elevated inflammatory markers (ESR 80mm/hr, CRP 150mg/L), and ... | SJIA severity: Active systemic features, despite multiple therapies.
Anemia complicates prognosis, potentially indicating macrophage activation.
Growth failure signifies chronic inflammation’s impact on development.
Delayed bone age predicts shorter adult stature potential.
Methotrexate response suboptimal; suggests ag... | # Prognostic Assessment: Systemic Juvenile Idiopathic Arthritis (SJIA) - 9-Month-Old Female
This 9-month-old infant with SJIA presents a complex prognostic challenge due to multiple high-risk factors and interacting conditions. Her disease course is characterized by significant systemic involvement, suboptimal respons... | prognostic |
A 9-year-old Hispanic male with a history of severe sickle cell disease (HbSS) presents to the PICU following a vaso-occlusive crisis complicated by acute chest syndrome (ACS). He initially responded to hydroxyurea and chronic transfusions, but adherence has been poor due to family relocation and socioeconomic challeng... | Sickle cell disease severity: HbSS, frequent acute crises.
Acute chest syndrome: Significant respiratory compromise, bilateral infiltrates.
Chronic kidney disease: Stage 2, impacts overall health.
Splenectomy history: Increased infection risk, poor prognosis.
Poor adherence: Hydroxyurea, transfusions, worsening control... | # Prognostic Assessment for a 9-Year-Old Male with Severe Sickle Cell Disease and Acute Chest Syndrome
This case presents a complex scenario with multiple interacting factors influencing prognosis. The patient’s severe sickle cell disease, complicated by ACS, chronic kidney disease, and socioeconomic challenges, neces... | prognostic |
Mr. David Chen, a 28-year-old male, presents with a confirmed diagnosis of Acute Promyelocytic Leukemia (APL) – PML-RARA positive, diagnosed 3 weeks ago. Initial WBC count was 85,000/µL with 90% blasts. He achieved hematologic remission after induction chemotherapy with all-trans retinoic acid (ATRA) and arsenic trioxi... | APL remission achieved, but MRD positivity present.
Capillary leak syndrome indicates higher risk of relapse.
Asthma complicates treatment; steroid use impacts outcomes.
Young age generally favors better prognosis.
Financial strain impacts adherence and supportive care.
Limited social support worsens psychological dist... | # Prognostic Assessment for Mr. David Chen – Acute Promyelocytic Leukemia
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen’s immediate prognosis is guarded due to the planned consolidation therapy with high-dose cytarabine. The risk of cytopenias, mucositis, and infections is significant. His history of asthma incre... | prognostic |
Mrs. Elena Rodriguez is an 82-year-old Hispanic female with a history of Stage IIIc serous ovarian cancer diagnosed 18 months ago. She initially responded well to neoadjuvant chemotherapy (carboplatin and paclitaxel) followed by interval debulking surgery and adjuvant maintenance therapy with olaparib. However, she pre... | Ovarian cancer recurrence, peritoneal spread indicates advanced stage.
BRCA1 mutation suggests potential PARP inhibitor sensitivity.
ECOG 2 signifies moderate functional impairment, impacting prognosis.
Albumin/prealbumin low, indicating malnutrition and poor reserve.
CRP elevated, reflecting systemic inflammation and ... | # Prognostic Assessment for Mrs. Elena Rodriguez
Mrs. Rodriguez presents with recurrent ovarian cancer, a challenging scenario requiring careful prognostic assessment. Her prognosis is significantly impacted by multiple factors, necessitating a nuanced approach.
**Short-Term Prognosis (Days to Weeks):**
Her immediate... | prognostic |
Mr. Elias Vance, a 68-year-old African American male, presents with established chronic mercury poisoning from artisanal gold mining exposure over 30 years. He initially presented 6 months ago with insidious onset of tremor, cognitive decline (MMSE 22/30), and peripheral neuropathy. Initial blood mercury level was 180 ... | Mercury levels remain elevated despite chelation therapy.
Neurological plateau suggests limited treatment response.
CKD stage 3 impairs mercury excretion, worsening toxicity.
Diabetes exacerbates neuropathy, complicating assessment.
*APOE4* homozygosity increases dementia risk, accelerates decline.
Age 68 increases vul... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case of chronic mercury poisoning complicated by multiple comorbidities and functional decline, making accurate prognosis challenging. His established neurological damage, persistent elevated mercury levels despite chelation, and genetic predispo... | prognostic |
An 8-year-old African American male presents with a 6-month history of progressive vision loss in the left eye. Initial examination revealed a large choroidal melanoma (diameter 15mm, thickness 8mm) in the posterior pole of the left eye, confirmed by fundus photography, optical coherence tomography (OCT), and B-scan ul... | Large tumor size indicates aggressive potential.
Posterior location complicates treatment options.
MERB mutation linked to higher metastasis risk.
Family history increases melanoma predisposition.
Spindle cell type often more aggressive.
No metastasis currently, favorable initial stage.
ECOG 0 suggests good functional ... | # Prognostic Assessment for Choroidal Melanoma
This 8-year-old patient with a large, posterior choroidal melanoma presents a complex prognostic challenge. Several factors contribute to a guarded prognosis, despite the absence of current metastatic disease.
**Short-Term Prognosis (Days to Weeks):**
Following plaque ra... | prognostic |
A 52-year-old female with a history of systemic lupus erythematosus (SLE) for 15 years, complicated by chronic kidney disease (CKD stage 3b, eGFR 35 mL/min/1.73m²), pulmonary hypertension (mean pulmonary artery pressure 45 mmHg confirmed by right heart catheterization), and recent diagnosis of Stage IIIB (T3N2M0) HER2-... | SLE impacts chemotherapy tolerance and surgical outcomes.
CKD stage 3b increases chemotherapy toxicity risk.
Pulmonary hypertension limits cardiopulmonary reserve.
Stage IIIB breast cancer indicates aggressive disease.
Positive lymph nodes worsen prognosis significantly.
ECOG 2 suggests reduced functional capacity.
Rec... | # Prognostic Assessment for a 52-Year-Old Female with Breast Cancer and Comorbidities
This patient presents a complex case with multiple interacting conditions significantly impacting her prognosis. Her breast cancer is aggressive (Stage IIIB, multiple positive lymph nodes), but her prognosis is further complicated by... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male presenting with worsening fatigue, easy bruising, and recurrent epistaxis over the past 3 months. He was diagnosed 6 months ago with Chronic Lymphocytic Leukemia (CLL), Rai Stage II, with 17p deletion identified on FISH testing. His initial absolute lymphocyte count was 45 x... | CLL stage II, 17p deletion: adverse prognostic features.
Rapid lymphocyte doubling time indicates aggressive disease.
Cytopenias (anemia, thrombocytopenia) worsen prognosis.
Renal insufficiency complicates treatment options.
Comorbidities increase treatment-related morbidity/mortality.
Decreasing functional status sign... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case of CLL with several factors influencing his prognosis. His diagnosis of CLL with a 17p deletion immediately places him in a high-risk category. The increasing absolute lymphocyte count and development of cytopenias (anemia and thr... | prognostic |
A 52-year-old female presents with known Crohn's Disease (CD), diagnosed 15 years ago, initially ileal-colonic, now predominantly colonic with stricturing phenotype. She has experienced frequent flares despite multiple therapies (azathioprine, infliximab, vedolizumab). Current flare presents with severe abdominal pain,... | Severe active CD, colonic stricture, poor response to therapies.
Prior fistulizing disease indicates aggressive disease course.
Weight loss suggests significant nutritional compromise and inflammation.
DVT history increases surgical risk and thromboembolic events.
Smoking history contributes to disease severity and com... | # Prognostic Assessment for Crohn's Disease
This 52-year-old female with long-standing Crohn's Disease presents a complex prognostic challenge due to multiple high-risk factors and a history of treatment failure. Her disease is characterized by a stricturing phenotype, frequent flares, and significant systemic inflamm... | prognostic |
A 16-year-old female, Anya Sharma, presents with a confirmed diagnosis of Systemic Lupus Erythematosus (SLE) established 18 months ago. Initial presentation included malar rash, serositis (pleuritis), and significant proteinuria (3.5g/24hr). She is currently managed with mycophenolate mofetil 1500mg daily, prednisone 1... | SLE severity: active nephritis, low complement, high anti-dsDNA.
Renal involvement: significant predictor of long-term outcomes.
Asthma: potential for increased infection risk with immunosuppression.
Anxiety/adherence: impacts treatment efficacy and disease control.
Socioeconomic factors: financial strain hinders optim... | # Prognostic Assessment for Anya Sharma – Systemic Lupus Erythematosus
**Short-Term Prognosis (Days to Weeks):**
Anya is at moderate risk for a near-term lupus flare, particularly renal. Her fluctuating proteinuria and persistently abnormal serologies suggest ongoing disease activity despite current therapy. The risk... | prognostic |
Mr. David Chen, a 28-year-old African American male, presents with a known diagnosis of Sickle Cell Disease (HbSS genotype) complicated by chronic kidney disease (CKD stage 3a, GFR 45-59 mL/min/1.73m²), pulmonary hypertension (confirmed by right heart catheterization - mPAP 42 mmHg), and a history of multiple acute che... | HbSS genotype indicates inherent disease severity.
CKD stage 3a worsens overall morbidity/mortality.
Pulmonary hypertension significantly impacts prognosis.
Recurrent ACS suggests aggressive disease course.
Osteomyelitis history: chronic pain, infection risk.
α-thalassemia trait exacerbates anemia severity.
Psychosocia... | # Prognostic Assessment for Mr. David Chen
Mr. Chen presents a complex case of Sickle Cell Disease with multiple significant comorbidities, demanding a nuanced prognostic assessment. His prognosis is guarded, with substantial risks in the short, medium, and long term.
**Short-Term Prognosis (Days to Weeks):**
Mr. Che... | prognostic |
A 26-day-old male infant, born at 28 weeks gestation (birth weight 950g), initially presented with respiratory distress syndrome requiring surfactant administration and mechanical ventilation. He developed Stage 3 Necrotizing Enterocolitis (NEC) requiring surgical resection of 50cm of small bowel on day 10. Post-operat... | Extreme prematurity significantly increases morbidity/mortality risk.
NEC stage 3 indicates severe intestinal compromise.
Short bowel syndrome complicates nutritional recovery.
Carbapenem-resistant *Klebsiella* infection is high risk.
PPHN adds significant cardiopulmonary strain.
Rising creatinine suggests acute kidney... | # Prognostic Assessment for a 26-Day-Old Male Infant with NEC, CLABSI, and PPHN
This infant presents a complex case with multiple interacting conditions significantly impacting his prognosis. His extreme prematurity, severe NEC, CLABSI with resistant organism, PPHN, and associated complications create a high-risk scen... | prognostic |
Mr. Kai Ito, a 28-year-old Japanese-American male, presents with a confirmed diagnosis of Stage IIIC, Grade 3 serous ovarian cancer. He was initially misdiagnosed with testicular torsion due to a large, painful scrotal mass, which was ultimately found to be a metastatic deposit from the primary ovarian tumor. Genetic t... | Stage IIIC indicates extensive disease spread.
Grade 3 signifies aggressive tumor biology.
BRCA1 mutation impacts treatment response.
Diabetes complicates surgical recovery, chemotherapy.
CKD increases chemotherapy toxicity risk.
Obesity affects surgical approach, drug metabolism.
Limited support impacts adherence, men... | # Prognostic Assessment for Mr. Kai Ito – Stage IIIC Serous Ovarian Cancer
**Short-Term Prognosis (Days to Weeks):**
Mr. Ito faces a high risk of complications related to initial chemotherapy (carboplatin/paclitaxel). His CKD and diabetes increase the likelihood of myelosuppression, neuropathy, and hyperglycemia. He ... | prognostic |
Mrs. Elena Rodriguez is an 82-year-old Hispanic female presenting with known Stage IV (T3N2M1) HER2-positive metastatic breast cancer, initially diagnosed 3 years ago. She initially responded well to trastuzumab and chemotherapy, achieving a partial remission lasting 18 months. Disease progression now involves multiple... | Advanced stage cancer significantly impacts overall survival.
Visceral crisis (pleural effusion, liver mets) worsens prognosis.
BRCA1 mutation suggests potential chemosensitivity, but…
ECOG 2 indicates reduced functional reserve, limiting options.
Comorbid CKD limits nephrotoxic chemotherapy choices.
Age >80 increases ... | # Prognostic Assessment for Mrs. Elena Rodriguez
**Short-Term Prognosis (Days to Weeks):**
Mrs. Rodriguez faces a high risk of complications in the immediate future. The impending vertebral compression fracture at L1 poses an immediate threat of severe pain, neurological compromise (though currently no deficits are re... | prognostic |
Mr. David Chen, a 48-year-old Vietnamese-American male, presents with a 5-year history of severe, uncontrolled asthma, initially diagnosed at age 35. He experiences frequent exacerbations (average 4 per year) requiring oral corticosteroids and occasional emergency department visits (2 in the past year). His asthma is c... | Asthma severity: frequent exacerbations, reduced lung function.
Smoking history: significant negative impact on lung health.
Comorbidities: hypertension and diabetes worsen outcomes.
Occupational exposure: ongoing irritant exposure increases risk.
Psychosocial factors: anxiety impacts adherence and quality of life.
Gen... | # Prognostic Assessment for Mr. David Chen
Mr. Chen presents a complex case of severe, uncontrolled asthma with multiple factors contributing to a guarded prognosis. His disease is characterized by significant physiological impairment, substantial comorbidity burden, and psychosocial challenges.
**Short-Term Prognosi... | prognostic |
Mrs. Eleanor Vance is an 82-year-old female with a history of hypertension, type 2 diabetes (well-controlled with metformin), and mild chronic kidney disease (eGFR 55 ml/min). She presented 3 months ago with progressive dyspnea and a non-productive cough. Initial workup, including chest X-ray and CT scan, revealed Stag... | Advanced stage NSCLC indicates poor overall prognosis.
PD-L1 positivity suggests potential immunotherapy response.
Stable disease after first-line therapy is encouraging.
Progressive spinal metastases cause neurological deficits.
Bone metastases increase fracture and pain risk.
Age and comorbidities worsen expected out... | # Prognostic Assessment for Mrs. Eleanor Vance
**Short-Term Prognosis (Days to Weeks):**
Mrs. Vance’s short-term prognosis is guarded due to progressive spinal cord compression and associated neurological deficits. Without intervention, continued deterioration of motor function and potential for complete paralysis are... | prognostic |
A 16-year-old Hispanic male, Mateo Rodriguez, presents 72 hours post-intentional overdose of diphenhydramine (estimated 1.5g) and alprazolam (estimated 3mg). He was found unresponsive by his mother. Initial presentation showed sinus tachycardia (130 bpm), dry mucous membranes, dilated pupils, altered mental status (GCS... | Significant anticholinergic toxicity, prolonged QTc, concerning arrhythmia risk.
Alprazolam adds CNS depression, complicating neurological recovery.
Asthma increases respiratory compromise risk during recovery.
Untreated depression: increased risk of future attempts/complications.
Family history of SCD suggests potenti... | # Prognostic Assessment: Diphenhydramine/Alprazolam Overdose - Mateo Rodriguez
**Short-Term Prognosis (Days to Weeks):**
Mateo’s immediate prognosis is guarded but improving. The primary concerns are cardiac arrhythmia (due to QTc prolongation), potential for delayed neurological sequelae, and development of acute kid... | prognostic |
A 28-year-old Hispanic male presents with a 6-month history of progressive nasal obstruction, epistaxis, and left facial swelling. Initial evaluation revealed a high-grade, undifferentiated sinonasal carcinoma. Biopsy confirmed poorly differentiated squamous cell carcinoma (SCC) with sarcomatoid features. Imaging (CT a... | Aggressive histology: sarcomatoid SCC indicates poor prognosis.
Advanced stage (IVA) signifies extensive local disease.
Smoking history: increases recurrence and second primary risk.
Diabetes: impairs wound healing, increases infection risk.
CKD: limits chemotherapy options, impacts recovery.
TP53 mutation: associated ... | # Prognostic Assessment: Sinonasal Squamous Cell Carcinoma
This 28-year-old male with Stage IVA sinonasal SCC presents a complex prognostic scenario due to multiple high-risk factors. His prognosis is significantly guarded, but not definitively hopeless, given the partial response to neoadjuvant chemotherapy.
**Short... | prognostic |
A 9-year-old male of Ashkenazi Jewish descent presents with newly diagnosed High-Risk B-cell Acute Lymphoblastic Leukemia (HR-B-ALL). Initial presentation included bone pain, fatigue, and petechiae. Physical exam reveals hepatosplenomegaly and lymphadenopathy. Complete blood count shows WBC 85,000/µL with 90% blasts. F... | HR-B-ALL diagnosis immediately indicates poorer prognosis.
Complex karyotype signifies high-risk genetic features.
NUDT15 variant increases 6-MP toxicity risk.
MRD positivity post-induction is concerning.
Age > 8 years correlates with lower remission rates.
Ashkenazi Jewish ancestry impacts drug metabolism.
Asthma adds... | # Prognostic Assessment for High-Risk B-ALL
This 9-year-old patient with HR-B-ALL presents a complex prognostic scenario. Several factors contribute to a guarded outlook, while others offer some degree of optimism.
**Short-Term Prognosis (Days to Weeks):**
The patient is currently in consolidation therapy. The immedi... | prognostic |
A 9-year-old female presents with a known diagnosis of Crohn’s Disease, ileocolonic involvement, diagnosed 2 years prior. Initial presentation involved abdominal pain, diarrhea (bloody), and failure to thrive. She has been on intermittent courses of oral prednisone and currently is managed with azathioprine 2mg/kg/day.... | Ileocolonic Crohn’s, active inflammation, significant disease extent.
Perianal fistulas indicate aggressive, fistulizing phenotype.
Recurrent CDI worsens prognosis, complicates management.
Low albumin reflects malnutrition, impaired healing capacity.
Azathioprine failure suggests potential steroid refractoriness.
Famil... | # Prognostic Assessment for Crohn's Disease
This 9-year-old female with Crohn’s Disease presents a complex case with multiple high-risk features, necessitating a cautious and nuanced prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
Guarded. The patient is at high risk for continued flares, recurrent *... | prognostic |
A 6-month-old female infant presents with a confirmed diagnosis of posterior urethral valves (PUV), diagnosed antenatally via prenatal ultrasound and subsequently confirmed with voiding cystourethrogram (VCUG). The VCUG demonstrated significant bladder outlet obstruction and bilateral hydronephrosis (Grade III). Initia... | PUV severity: Grade III hydronephrosis indicates moderate obstruction.
Early renal function decline: Creatinine elevated, GFR reduced.
Recurrent UTIs: Increase risk of renal scarring and decline.
Small for gestational age: Suggests potential developmental issues.
GERD complicates management: Impacts nutritional status ... | # Prognostic Assessment for Posterior Urethral Valves (PUV) in a 6-Month-Old Female
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is guarded. The infant is at high risk for acute kidney injury (AKI) due to ongoing obstruction and recurrent UTIs. Continued elevation of creatinine and declining GFR ... | prognostic |
Mr. David Okoro, a 52-year-old Nigerian-American male, presents with a confirmed diagnosis of Chronic Myeloid Leukemia (CML) in accelerated phase, diagnosed 6 months ago after presenting with fatigue, splenomegaly, and elevated white blood cell count. Initial cytogenetic analysis revealed t(9;22)(q34;q11.2) BCR-ABL1 po... | Accelerated phase CML indicates aggressive disease course.
Dasatinib resistance due to multiple mutations is concerning.
High blast percentage signifies rapid disease progression.
Poorly controlled diabetes worsens treatment tolerance.
Functional status severely impaired, impacting quality of life.
T315I mutation limit... | # Prognostic Assessment for Mr. David Okoro
**Short-Term Prognosis (Days to Weeks):**
Mr. Okoro faces a high risk of rapid disease progression and complications within the next few weeks. The accelerated phase, coupled with dasatinib resistance due to multiple mutations (including T315I), and increasing blast percenta... | prognostic |
A 52-year-old female with a history of poorly controlled Type 2 Diabetes Mellitus (HbA1c 9.8%), hypertension, and Stage 3 Chronic Kidney Disease (eGFR 45 mL/min/1.73m²) presents to the Emergency Department with acute decompensated heart failure (ADHF). She reports worsening shortness of breath over the past week, now a... | ADHF severity: acutely decompensated, high BNP, respiratory distress.
Diabetes: poor control worsens cardiac and renal outcomes.
CKD stage 3: increases cardiovascular risk, limits treatment.
Hypertension: contributes to cardiac strain, poor prognosis.
Hyperkalemia: potential arrhythmia risk, treatment challenges.
Socia... | # Prognostic Assessment for Acute Decompensated Heart Failure
This 52-year-old female with ADHF presents a complex prognostic challenge due to multiple interacting comorbidities and psychosocial factors. Her prognosis is guarded, with significant risks in the short, medium, and long term.
**Short-Term Prognosis (Days... | prognostic |
A 9-month-old male infant of non-European ancestry (African American) presents with a confirmed diagnosis of congenital hip dysplasia (CHD), specifically bilateral dislocatable hips identified on neonatal screening ultrasound. Initial treatment involved a Pavlik harness applied at 6 weeks of age, but adherence was inco... | Bilateral dislocation indicates severe CHD severity.
Poor harness adherence worsens dysplasia progression.
Delayed sitting impacts hip reduction potential.
Family history suggests osteoarthritis predisposition.
COL2A1 VUS raises connective tissue concern.
Low motor score predicts poorer functional outcome.
Respiratory ... | # Prognostic Assessment: Bilateral Congenital Hip Dysplasia (CHD) - 9-Month-Old Male
This 9-month-old infant with bilateral, persistent CHD presents a complex prognostic challenge due to multiple interacting risk factors. The initial failure of Pavlik harness treatment, coupled with developmental delay and socioeconom... | prognostic |
Mr. David Chen, a 28-year-old Asian male, presents for follow-up 6 months post-acute Myocarditis. Initial presentation involved chest pain, dyspnea, and palpitations following a viral upper respiratory infection (confirmed Influenza A). Cardiac MRI revealed global left ventricular dysfunction (EF 35%, indexed LV volume... | Myocarditis severity: moderate, persistent LV dysfunction present.
Young age: generally favorable, but inflammation complicates.
Reduced EF: significant predictor of adverse outcomes.
LGE presence: indicates fibrosis, worse prognosis.
Family history: premature CAD increases risk.
Psychosocial stress: negatively impacts... | # Prognostic Assessment for Mr. David Chen
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen is currently stable on GDMT, but remains at risk for arrhythmia, particularly ventricular tachycardia, given the residual LV dysfunction and presence of LGE. Acute decompensation of heart failure is also possible, especially ... | prognostic |
A 6-month-old female infant of Nigerian descent presents with a history of severe, refractory food protein-induced enterocolitis syndrome (FPIES) triggered by rice and oat. Initial presentation at 3 months involved profuse vomiting, lethargy, and pallor 1-4 hours post-ingestion, requiring multiple ED visits and one bri... | FPIES severity: recurrent, requiring ED visits, ICU admission.
Multiple triggers: rice and oat increase disease complexity.
Eczema adds atopic march risk, impacting quality of life.
FLG2 mutation: increases risk of atopic disease severity.
Failure to thrive: indicates nutritional compromise, poor prognosis.
Iron defici... | # Prognostic Assessment for Refractory FPIES and Atopic Dermatitis
This 6-month-old infant with refractory FPIES and co-existing atopic dermatitis presents a complex prognostic challenge. Her disease course is complicated by multiple food triggers, genetic predisposition, failure to thrive, psychosocial stressors, and... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male presenting for follow-up regarding his diagnosis of High-Risk Myelodysplastic Syndrome (MDS), specifically RAEB-2, established 6 months ago via bone marrow biopsy. He initially presented with fatigue, recurrent infections (pneumonia and cellulitis in the past year), and easy ... | RAEB-2 MDS indicates aggressive disease course.
Complex karyotype signifies poor prognostic features.
Azacitidine response is incomplete, limiting benefit.
Age >70 increases risk of treatment-related mortality.
CKD stage 3 complicates treatment options and prognosis.
Poorly controlled diabetes worsens overall health st... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case of high-risk MDS with multiple factors impacting prognosis. His RAEB-2 subtype, complex karyotype, and incomplete response to azacitidine all point towards a significantly unfavorable outlook.
**Short-Term Prognosis (Days to Week... | prognostic |
Mrs. Elena Rodriguez is an 82-year-old Hispanic female admitted to the hospital with acute decompensated heart failure (ADHF) exacerbation. She has a history of ischemic cardiomyopathy (EF 30%, NYHA Class III), chronic kidney disease (CKD stage 3b, eGFR 35 mL/min/1.73m²), type 2 diabetes mellitus (HbA1c 8.2%), and mild... | Cardiomyopathy severity: reduced ejection fraction, NYHA Class III.
CKD stage 3b: increases risk of adverse outcomes significantly.
Diabetes: accelerates cardiovascular disease progression, poor healing.
MCI: impacts medication adherence, self-management abilities.
Age 82: inherent increased vulnerability, reduced phys... | # Prognostic Assessment for Mrs. Elena Rodriguez
Mrs. Rodriguez presents a complex geriatric syndrome with multiple interacting conditions significantly impacting her prognosis. Her ADHF exacerbation is superimposed on a background of ischemic cardiomyopathy, CKD, diabetes, MCI, and social isolation, compounded by gen... | prognostic |
Ethan, a 16-year-old male, presents with a confirmed diagnosis of Bipolar I Disorder (most recent manic episode 6 months ago, currently euthymic on lithium 900mg daily and risperidone 2mg daily). He was initially diagnosed at age 14 following a severe manic episode requiring hospitalization. His father has a history of... | Bipolar I, adolescent onset, indicates more severe course.
Family history significantly elevates risk for recurrence/severity.
Comorbid substance use worsens illness trajectory.
Non-suicidal self-injury signals increased vulnerability.
Executive dysfunction impacts functional recovery.
Chronic hopelessness suggests tre... | # Prognostic Assessment for Ethan – Bipolar I Disorder
**Short-Term Prognosis (Days to Weeks):**
Ethan is currently euthymic on medication, suggesting a relatively stable short-term outlook *if* medication adherence is maintained. However, his ambivalence towards medication and ongoing cannabis use pose immediate risk... | prognostic |
Mr. David Chen, a 52-year-old African American male, presents with known Rutherford category IV chronic limb ischemia (CLI) of the left lower extremity, secondary to Type 2 Diabetes Mellitus and peripheral artery disease (PAD). He was diagnosed with CLI 6 months ago after presenting with rest pain. Initial angiography ... | CLI severity: Rutherford IV, non-healing ulcer, high amputation risk.
Diabetes: Poor glycemic control worsens vascular disease progression.
Renal function: CKD stage 3a limits revascularization options.
Restenosis: Failed prior intervention indicates complex disease.
Smoking history: Significant contributor to PAD and ... | # Prognostic Assessment for Mr. David Chen
Mr. Chen presents a complex case of CLI with multiple high-risk factors, significantly impacting his prognosis. His Rutherford IV classification, coupled with non-healing ulceration and prior failed intervention, indicates a severe disease state.
**Short-Term Prognosis (Days... | prognostic |
Ethan is an 8-year-old male diagnosed with Severe, Persistent Major Depressive Disorder (MDD) with anxious distress and comorbid Attention-Deficit/Hyperactivity Disorder, Combined Presentation (ADHD-C). His MDD onset was 18 months ago, initially triggered by parental separation and subsequent relocation. Symptoms inclu... | Severe MDD, poor initial treatment response, concerning.
Comorbid ADHD complicates treatment and prognosis.
Family history of mood disorder: increased risk.
Parental separation, financial strain, adverse childhood events.
Prior self-harm, moderate passive suicidal ideation.
Functional impairment: school, behavior, weig... | # Prognostic Assessment for Ethan
**Short-Term Prognosis (Days to Weeks):**
Ethan is at *high risk* for continued depressive symptoms and potential escalation of suicidal ideation. Given the limited response to Fluoxetine and the presence of moderate passive suicidal ideation, close monitoring (daily check-ins) is cru... | prognostic |
Mr. David Okoro, a 52-year-old Nigerian-American male, presents for follow-up regarding his recently diagnosed Type 1 Diabetes Mellitus (T1DM) complicated by early-stage (Stage 2) Chronic Kidney Disease (CKD). He was diagnosed with T1DM 6 months ago after presenting with polyuria, polydipsia, and unintentional weight l... | T1DM severity: Poor control, recent diagnosis, high HbA1c.
CKD stage: Early, but declining eGFR indicates progression risk.
Hypertension: Poorly controlled, accelerates CKD and CVD.
Cardiovascular risk: Family history, dyslipidemia, hypertension present.
Adherence: Inconsistent insulin and medication taking is critical... | # Prognostic Assessment for Mr. David Okoro
Mr. Okoro presents a complex case with interacting conditions significantly impacting his prognosis. His T1DM, complicated by early CKD and poorly controlled hypertension, coupled with psychosocial and occupational challenges, necessitates a nuanced assessment.
**Short-Term... | prognostic |
A 28-year-old male presents with a 3-year history of rapidly progressive, generalized morphea. Initial presentation involved localized plaques on the trunk, which have expanded to involve the limbs, face, and scalp. Skin biopsies confirmed morphea profunda with significant sclerosis extending into the subcutaneous tiss... | Generalized morphea profunda indicates aggressive disease course.
Rapid progression over three years is a negative prognosticator.
Positive ANA suggests potential for systemic involvement.
Renal insufficiency complicates management and worsens prognosis.
Pulmonary hypertension indicates end-organ damage, poor prognosis... | # Prognostic Assessment: Generalized Morphea Profunda
This 28-year-old male with generalized morphea profunda presents a complex case with multiple high-risk features, necessitating a detailed prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
Continued disease progression is likely. Expect worsening sk... | prognostic |
Mrs. Evelyn Reed is a 72-year-old African American female presenting for follow-up regarding Stage IV (T2N3M1) non-small cell lung cancer (NSCLC), adenocarcinoma histology, diagnosed 6 months ago. She initially presented with progressive dyspnea and a chronic cough. Molecular testing revealed an EGFR mutation (exon 19 ... | Advanced stage NSCLC indicates poor overall survival.
EGFR mutation resistance signifies treatment failure.
Bone metastases imply aggressive disease progression.
ECOG 3 status reflects significant functional decline.
Diabetes and CKD worsen treatment tolerance.
APOE4 allele linked to cognitive decline, poorer outcomes.... | # Prognostic Assessment for Mrs. Evelyn Reed
**Short-Term Prognosis (Days to Weeks):** Mrs. Reed’s short-term prognosis is guarded. Her uncontrolled pain, declining functional status, and progressive disease suggest a high risk of rapid deterioration. Focus will be on aggressive symptom management, particularly pain c... | prognostic |
Mr. David Miller is a 52-year-old male with a confirmed diagnosis of Amyotrophic Lateral Sclerosis (ALS) – specifically, the bulbar-onset variant, diagnosed 18 months ago. Initial symptom was slurred speech, progressing to dysphagia and fasciculations in the tongue. He currently uses a feeding tube for nutrition. He ha... | Bulbar onset ALS indicates faster disease progression.
Rapid FVC decline signals imminent respiratory compromise.
Cardiovascular disease increases mortality risk.
Smoking history contributes to respiratory vulnerability.
Social isolation exacerbates psychological distress.
ALSFRS-R score indicates moderate disease seve... | # Prognostic Assessment for Mr. David Miller – ALS
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller is at high risk for worsening dysphagia and increasing respiratory insufficiency. He will likely require escalation of respiratory support, potentially including non-invasive ventilation (NIV), within the next few w... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male admitted to the ICU following a witnessed out-of-hospital cardiac arrest (OHCA) secondary to a large anterior ST-elevation myocardial infarction (STEMI). ROSC was achieved after 18 minutes of CPR and administration of epinephrine. He was immediately taken to the cardiac cathe... | OHCA with prolonged CPR: poor neurological outcome risk.
STEMI post-ROSC: myocardial dysfunction, arrhythmia potential.
CKD stage 3a: increased mortality, slower recovery.
COPD exacerbation risk: respiratory failure, prolonged ventilation.
Hypoxic-ischemic encephalopathy: neurological sequelae likely.
Age 72: increased... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon’s short-term prognosis is guarded. He remains at high risk for multi-organ dysfunction, particularly neurological. The likelihood of survival to discharge is estimated at 30-40%. The primary risks include refract... | prognostic |
A 48-year-old female presents to the ED following intentional ingestion of a large quantity of acetaminophen (estimated 30g, 60 x 500mg tablets) approximately 6 hours prior to arrival. She has a history of chronic depression, poorly controlled with sertraline 100mg daily, and a recent diagnosis of fibromyalgia. She rep... | Acetaminophen toxicity: severe, potential for acute liver failure.
Delayed presentation complicates accurate toxicity assessment.
Pre-existing depression increases suicide risk, complicates management.
Fibromyalgia contributes to chronic pain, functional impairment.
Benzodiazepine use increases risk of hepatic encephal... | # Prognostic Assessment: Acetaminophen Overdose with Comorbidities
This 48-year-old female with a massive acetaminophen overdose presents a complex prognostic challenge due to interacting medical and psychosocial factors. Her presentation, despite delayed treatment, indicates significant acute liver injury.
**Short-T... | prognostic |
A 6-month-old male infant presents with worsening respiratory distress. He was born prematurely at 28 weeks gestation (birth weight 1100g) and required prolonged mechanical ventilation, complicated by a presumed community-acquired pneumonia treated with ampicillin and gentamicin. He was discharged home on supplemental ... | Prematurity increases risk of respiratory morbidity.
Prior pneumonia suggests underlying lung vulnerability.
RSV infection is common, severity varies greatly.
Gastroesophageal reflux complicates respiratory management.
Family history raises cystic fibrosis suspicion.
Developmental delay indicates broader health issues.... | # Prognostic Assessment for 6-Month-Old Male with RSV and Complex History
This infant presents a complex case with multiple interacting factors influencing his prognosis. His prematurity, prior pneumonia, RSV infection, gastroesophageal reflux, potential cystic fibrosis, and developmental delay all contribute to a hei... | prognostic |
A 52-year-old African American female with a 20-pack-year smoking history presents to the ICU following a motor vehicle collision. She sustained a traumatic brain injury (TBI) – diffuse axonal injury (DAI), classified as severe (GCS 6 post-resuscitation). She also has a right femur fracture and multiple rib fractures w... | Severe TBI (DAI) dictates significant neurological morbidity/mortality.
CRKP bacteremia increases risk of sepsis and multi-organ failure.
Diabetes impairs immune function, delaying wound healing/infection control.
CKD compromises renal clearance, impacting drug metabolism/electrolyte balance.
Hypertension contributes t... | # Prognostic Assessment for 52-Year-Old Female with Severe TBI, CRKP, and Comorbidities
This patient presents a complex case with multiple interacting factors significantly impacting her prognosis. Her severe DAI, coupled with CRKP bacteremia and significant comorbidities, creates a high-risk scenario.
**Short-Term P... | prognostic |
A 28-year-old male presents with a known diagnosis of Systemic Lupus Erythematosus (SLE) established 5 years ago, initially presenting with serositis and non-erosive arthritis. He has been on mycophenolate mofetil 1g BID and low-dose prednisone (5mg daily) for disease control. Over the past 6 months, he’s experienced i... | SLE severity: Active Class IV nephritis, increasing disease activity.
Renal involvement: Proteinuria, declining eGFR, biopsy findings critical.
Prior flare: History of severe flare indicates aggressive disease.
Comorbid hypertension: Increases cardiovascular risk, renal damage.
Psychosocial factors: Anxiety, depression... | # Prognostic Assessment for a 28-Year-Old Male with SLE and Class IV Lupus Nephritis
This patient presents a complex case of SLE with significant prognostic concerns due to active lupus nephritis, prior severe flare, comorbidities, and psychosocial factors. A comprehensive assessment is crucial to guide management and... | prognostic |
Mr. David Miller is a 52-year-old male presenting for rheumatology follow-up. He was diagnosed with seropositive Rheumatoid Arthritis (RA) 8 years ago. Initially, he responded well to methotrexate, but experienced disease flares with increasing methotrexate doses. He was switched to a TNF inhibitor (etanercept) 5 years... | RA seropositivity indicates more aggressive disease course.
Multiple biologic failures suggest poor long-term response.
ILD presence complicates treatment and worsens prognosis.
Prior MI increases cardiovascular risk and mortality.
Smoking exacerbates RA and ILD progression.
Functional limitations impact quality of lif... | # Prognostic Assessment for Mr. David Miller
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller is likely to continue experiencing significant pain, fatigue, and functional limitations. An acute flare is probable given his current disease activity. There is a moderate risk of opportunistic infection due to ongoing i... | prognostic |
Mr. Elias Vance is a 68-year-old African American male with a 3-year history of Systemic Lupus Erythematosus (SLE) diagnosed based on ACR/EULAR criteria. He initially presented with polyarthritis, serositis, and a positive ANA with anti-dsDNA antibodies. His disease was initially controlled with mycophenolate mofetil, ... | SLE nephritis class IV indicates significant disease severity.
High ISN/RPS score predicts renal progression risk.
African American ethnicity increases lupus nephritis risk.
CKD stage 3a limits renal reserve, worsens prognosis.
Low C3/C4 suggest ongoing complement activation.
Anti-dsDNA elevation indicates active disea... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case of SLE with significant renal involvement and multiple risk factors for a poor prognosis. His established diagnosis of Class IV lupus nephritis, coupled with a high ISN/RPS score, indicates a substantial risk of progressive renal damage and ... | prognostic |
Mr. David Miller is a 52-year-old male presenting for follow-up regarding recently diagnosed Stage IIIB (T3N2M0) non-small cell lung cancer (NSCLC), adenocarcinoma histology. He was diagnosed 6 weeks ago after presenting with a persistent cough and unintentional weight loss. He is a former smoker with a 35 pack-year hi... | NSCLC stage IIIB indicates advanced, potentially aggressive disease.
Smoking history significantly elevates recurrence and mortality risk.
Diabetes complicates treatment and worsens overall prognosis.
Diabetic nephropathy limits chemotherapy dose intensity.
Depression impacts treatment adherence and quality of life.
EC... | # Prognostic Assessment for Mr. David Miller
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller’s short-term prognosis is relatively stable given his partial response to chemotherapy. However, he remains at risk for chemotherapy-related complications (nausea, fatigue, myelosuppression) and potential infections due t... | prognostic |
An 8-year-old male of African American descent presents with a confirmed diagnosis of Severe Hemophilia A (Factor VIII deficiency <1% activity). He experienced a significant intracranial hemorrhage (ICH) six months prior, requiring prolonged ICU admission and resulting in left hemiparesis. He currently requires regular... | Severe Hemophilia A: inherently high bleeding risk.
Prior ICH: significant neurological sequelae, poor predictor.
Deep intronic mutation: inhibitor development risk increased.
Low Factor VIII levels: necessitates frequent replacement.
Developing inhibitor: treatment efficacy significantly compromised.
Hemiparesis: impa... | # Prognostic Assessment: Severe Hemophilia A with Complications
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is guarded due to the rising Factor VIII inhibitor titer. The patient is at high risk for breakthrough bleeds, particularly spontaneous ones, despite ongoing Factor VIII replacement. The r... | prognostic |
Eight-year-old female, Maya, presents post-operatively following resection of a high-grade glioma (diffuse intrinsic pontine glioma - DIPG) with near total resection achieved. Diagnosis confirmed by biopsy and genetic testing reveals an *H3 K27M* mutation. Pre-operative neurological exam showed mild ataxia and dysarthr... | DIPG, *H3 K27M* mutation: inherently poor prognosis.
Near total resection offers temporary benefit, not curative.
Post-operative neurological deficits worsen overall outlook.
KPS decline indicates rapid functional deterioration.
Asthma: manageable comorbidity, minimal prognostic impact.
Single parent, financial strain:... | # Prognostic Assessment for Maya - DIPG
**Short-Term Prognosis (Days to Weeks):**
Maya’s immediate prognosis is guarded. The new-onset hemiparesis and cranial nerve palsy indicate ongoing neurological compromise despite the resection and radiation. She will likely require continued intensive supportive care, including... | prognostic |
A 48-year-old female presents to the ED with worsening shortness of breath and productive cough. She has a known history of Systemic Lupus Erythematosus (SLE) diagnosed 15 years ago, currently managed with mycophenolate mofetil 1g BID and low-dose prednisone (5mg daily). She also has a history of pulmonary hypertension... | SLE exacerbation complicates respiratory illness severity.
Pre-existing PH significantly worsens respiratory prognosis.
Acute kidney injury indicates disease severity/complication.
Elevated BNP suggests significant cardiac strain.
Positive procalcitonin suggests bacterial pneumonia.
Limited social support hinders recov... | # Prognostic Assessment for 48-Year-Old Female with SLE, PH, and Pneumonia
This patient presents a complex case with multiple interacting conditions significantly impacting her prognosis. Her underlying SLE and PH, coupled with an acute pneumonia and acute kidney injury, create a high-risk scenario.
**Short-Term Prog... | prognostic |
A 68-year-old Vietnamese-American woman, Mrs. Nguyen, presents with Stage IIIC (T3N2M0) HER2-positive invasive ductal carcinoma of the right breast, diagnosed 6 months ago. She initially underwent neoadjuvant chemotherapy (AC-T regimen) followed by lumpectomy and sentinel lymph node biopsy revealing 3 positive nodes. P... | Stage IIIC HER2+ breast cancer: aggressive disease.
BRCA1 mutation: increased recurrence risk.
Positive lymph nodes: higher metastatic potential.
Rising CA 15-3: suggests disease progression.
CKD stage 3a: limits treatment options.
Diabetes & hypertension: cardiovascular risk increased.
Anxiety/depression: impacts adhe... | # Prognostic Assessment for Mrs. Nguyen
**Short-Term Prognosis (Days to Weeks):**
Mrs. Nguyen is currently stable but at risk of disease progression given the rising CA 15-3. Short-term complications are more likely related to her comorbidities (e.g., infection related to CKD, cardiovascular event). Her immediate pro... | prognostic |
Mr. Arthur Penhaligon is a 68-year-old male with a 5-year history of Parkinson’s Disease (PD), Hoehn & Yahr stage III, presenting with worsening depressive symptoms over the past 6 months. He was initially diagnosed with mild depression concurrent with PD onset, managed with sertraline 50mg daily. Recent neuropsycholog... | PD stage III indicates moderate disease severity.
Comorbid depression significantly worsens PD prognosis.
Cognitive decline (MMSE 24) increases vulnerability.
Social isolation exacerbates depressive symptoms.
Financial strain adds to psychological distress.
Frequent ‘off’ periods impact functional capacity.
History of ... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case requiring careful prognostic assessment due to the interplay of Parkinson’s Disease, comorbid depression, cognitive decline, and psychosocial stressors.
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon is at moderate ris... | prognostic |
Mrs. Eleanor Vance is a 93-year-old female admitted with acute urinary retention secondary to a large pelvic mass. She has a history of well-controlled type 2 diabetes, hypertension, and mild cognitive impairment (MMSE 24/30). Initial evaluation revealed a 7cm, fixed, irregular bladder mass concerning for high-grade ur... | High-grade urothelial cancer; aggressive potential exists.
Advanced age significantly impacts treatment tolerance.
Comorbidities (diabetes, hypertension) increase surgical risk.
Mild cognitive impairment complicates informed consent.
Local invasion suggests higher stage, worse prognosis.
ECOG 1 indicates relatively goo... | # Prognostic Assessment for Mrs. Eleanor Vance
**Established Diagnosis:** High-grade urothelial carcinoma of the bladder, clinically T3N1M0 (suspected).
**Short-Term Prognosis (Days to Weeks):**
Mrs. Vance faces immediate risks related to acute urinary retention and potential renal failure from hydronephrosis. Withou... | prognostic |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.